logo
AI Icon𝛼SK or Search
ENTITY
HUTCHMED

HUTCHMED (HCM US)

56
Analysis
Health Care • Hong Kong
HUTCHMED is an innovative, commercial-stage biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing targeted therapies and immunotherapies for cancer and immunological diseases. The company has several novel oncology products marketed in China, with one also approved in the US, Europe, and Japan. HUTCHMED was founded in 2000 and is headquartered in Hong Kong.
more
bullish•HUTCHMED
•22 Apr 2020 14:51•Issuer-paid

Hutchison China MediTech - Fortune favours the brave

Notwithstanding the COVID-19 pandemic challenges, Hutchison China MediTech (HCM) remains on track for potential approval and launches of two...

Logo
Share
bullish•HUTCHMED
•24 Mar 2020 20:37•Issuer-paid

Hutchison China MediTech - From innovation to oncology commercialization

Hutchison China MediTech’s (HCM’s) investment case is focused on evolution into a global R&D and commercial-stage biopharma company with a...

Logo
Share
bullish•HUTCHMED
•23 Mar 2020 22:08•Issuer-paid

Hutchison China MediTech - From innovation to oncology commercialisation

Hutchison China MediTech’s (HCM’s) investment case is focused on evolution into a global R&D and commercial-stage biopharma company with a...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x